1978
DOI: 10.1016/0022-510x(78)90204-6
|View full text |Cite
|
Sign up to set email alerts
|

Protein fractions of lumbar, cisternal, and ventricular cerebrospinal fluid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
62
1
1

Year Published

1984
1984
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 119 publications
(68 citation statements)
references
References 14 publications
4
62
1
1
Order By: Relevance
“…Previous studies report a gradient in protein concentration between the ventricle and lumbar regions (10,11 ). Individual protein concentrations have also been shown to change up to 3.5-fold between these 2 regions (12 ).…”
Section: Gel Image Analysismentioning
confidence: 94%
“…Previous studies report a gradient in protein concentration between the ventricle and lumbar regions (10,11 ). Individual protein concentrations have also been shown to change up to 3.5-fold between these 2 regions (12 ).…”
Section: Gel Image Analysismentioning
confidence: 94%
“…The CSF protein content mainly depends on the permeability of plexus and meningeal capillaries and increases under conditions of reduced CSF turnover [7]. There is no doubt about a rostrocaudal gradient of CSF protein due to successive addition of serum protein during the CSF flow from the ventricles to the cranial and spinal subarachnoid space [7].…”
Section: Discussionmentioning
confidence: 99%
“…In the same way, levels of foscarnet in CSF are lower than those observed in brain. CSF drug concentrations are frequently lower than those of the cerebral extracellular fluid and the brain tissue, overall when CSF is obtained from ventricles or the cisterna magna (6,18,26). However, the presence of an AUC in the brain sixfold higher than that in the CSF suggests that, at least in this animal, there may be a high efflux clearance of foscarnet from CSF.…”
mentioning
confidence: 95%
“…It would be expected that the concentrations of foscarnet in these tissues would be similar to or higher than those observed in rabbits, since in humans the V ss of foscarnet is higher and the half-life is longer than those in rabbits (2,24,26). From our study, it cannot be ruled out that the current dosages of foscarnet during the maintenance phase of CMV retinitis (90 to 120 mg/day, in a single dose) give rise to subtherapeutic concentrations in the retina during part of the day and that this may be a factor in the progression of the disease.…”
mentioning
confidence: 99%